ACE2 and COVID-19: The endothelial cell expression of angiotensin-converting enzyme 2, which is the target receptor of SARS-CoV-2 and involved in cardiometabolic conditions including hypertension and diabetes (Batiha et al., 2021), may partially explain this observed vulnerability of the cerebrovasculature to COVID-19.